New Article Directory Alaska: October 2009

Monday, 26 October 2009

Nimodipino MF

Nimodipino MF may be available in the countries listed below.

Ingredient matches for Nimodipino MF

Nimodipine

Nimodipine is reported as an ingredient of Nimodipino MF in the following countries:

Peru

International Drug Name Search

Sunday, 25 October 2009

Paracetamol / Codeine Actavis

Paracetamol / Codeine Actavis may be available in the countries listed below.

Ingredient matches for Paracetamol / Codeine Actavis

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Paracetamol / Codeine Actavis in the following countries:

Netherlands

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol / Codeine Actavis in the following countries:

Netherlands

International Drug Name Search

Axokine

Axokine may be available in the countries listed below.

Ingredient matches for Axokine

Hydroxychloroquine

Hydroxychloroquine sulfate (a derivative of Hydroxychloroquine) is reported as an ingredient of Axokine in the following countries:

Argentina

International Drug Name Search

Monday, 19 October 2009

Adcar AC

Adcar AC may be available in the countries listed below.

Ingredient matches for Adcar AC

Carbazochrome

Carbazochrome sodium sulfonate (a derivative of Carbazochrome) is reported as an ingredient of Adcar AC in the following countries:

Japan

International Drug Name Search

Saturday, 17 October 2009

Metizol

Metizol may be available in the countries listed below.

Ingredient matches for Metizol

Thiamazole

Thiamazole is reported as an ingredient of Metizol in the following countries:

Lithuania

Poland

International Drug Name Search

Tuesday, 13 October 2009

Avelox

Avelox is a brand name of moxifloxacin, approved by the FDA in the following formulation(s):

AVELOX (moxifloxacin hydrochloride - tablet; oral)

Manufacturer: BAYER HLTHCARE

Approval date: December 10, 1999

Strength(s): EQ 400MG BASE ^[RLD]

Has a generic version of Avelox been approved?

No. There is currently no therapeutically equivalent version of Avelox available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Avelox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

7-(1-pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives
Patent 4,990,517
Issued: February 5, 1991
Inventor(s): Petersen; Uwe & Schenke; Thomas & Krebs; Andreas & Grohe; Klaus & Schriewer; Michael & Haller; Ingo & Metzger; Karl G. & Endermann; Rainer & Zeiler; Hans-Joachim
Assignee(s): Bayer Aktiengesellschaft
7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives, of the formula ##STR1## in which X.sup.1 is halogen, X.sup.2 is hydrogen, halogen, amino or other radical, R.sup.1 is alkyl, cycloalkyl, optionally substituted phenyl or other radical, R.sup.2 is hydrogen, alkyl or a dioxolylmethyl radical, R.sup.3 is ##STR2## A is N, CH, C-halogen, or the like, or forms a bridge with R.sup.1, and addition products thereof.
Patent expiration dates:
- December 8, 2011
  ✓
  Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
  ✓
  Drug substance
  ✓
  Drug product

7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives
Patent 5,607,942
Issued: March 4, 1997
Inventor(s): Petersen; Uwe & Schenke; Thomas & Krebs; Andreas & Grohe; Klaus & Schriewer; Michael & Haller; Ingo & Metzger; Karl G. & Endermann; Rainer & Zeiler; Hans-Joachim
Assignee(s): Bayer Aktiengesellschaft
7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives, of the formula ##STR1## in which X.sup.1 is halogen, X.sup.2 is hydrogen, halogen, amino or other radical, R.sup.1 is alkyl, cycloalkyl, optionally substituted phenyl or other radical, R.sup.2 is hydrogen, alkyl or a dioxolylmethyl radical, R.sup.3 is ##STR2## and A is N, CH, C-halogen, or the like, or forms a bridge with R.sup.1, and addition products thereof.
Patent expiration dates:
- March 4, 2014
  ✓
  Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT

Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
Patent 5,849,752
Issued: December 15, 1998
Inventor(s): Grunenberg; Alfons & Bosche; Patrick
Assignee(s): Bayer Aktiengesellschaft
The invention relates to the new monohydrate of 1-cyclopropyl-7-(›S,S!-2,8-diazabicyclo-›4.3.0!non-8-yl)6-fluoro-1,4-dihyd ro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride (CDCH), a process for its preparation and pharmaceutical formulations which comprise this monohydrate as the active compound.
Patent expiration dates:
- December 5, 2016
  ✓
  Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT

Pharmaceutical moxifloxacin preparation
Patent 6,610,327
Issued: August 26, 2003
Inventor(s): Patrick; Bosché & Hans Friedrich; Mahler & Claus; Weisemann
Assignee(s): Bayer Aktiengesellschaft
The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
Patent expiration dates:
- October 29, 2019
  ✓
  Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
  ✓
  Drug product

Becaplermin is used for:

Healing skin ulcers of the lower legs or feet caused by diabetes. It is used in combination with proper wound care.

Becaplermin is a wound-healing agent. It works by helping the body to form cells involved in wound healing and tissue growth.

Do NOT use Becaplermin if:

you are allergic to any ingredient in Becaplermin

you have a cancerous growth or tumor at the site where Becaplermin is to be applied

Contact your doctor or health care provider right away if any of these apply to you.

Before using Becaplermin:

Some medical conditions may interact with Becaplermin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding

if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

if you have allergies to medicines, foods, or other substances

if you have a history of cancer

Some MEDICINES MAY INTERACT with Becaplermin. Because little, if any, of Becaplermin is absorbed into the blood, the risk of it interacting with another medicine is low.

Ask your health care provider if Becaplermin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Becaplermin:

Use Becaplermin as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Wash hands thoroughly before applying.

Make sure the tip of the tube does not touch the ulcer or any other surface. Replace cap on tube tightly after each use.

Apply medicine with a tongue depressor, cotton swab, or other application aid.

Squeeze the doctor-recommended length of gel onto a clean, firm, nonabsorbent surface, such as wax paper. Spread the measured gel over the ulcer surface evenly with the application aid. Cover with a saline-moistened gauze dressing that only covers the wound, not the surrounding healthy skin. Wrap a gauze bandage over the dressing.

After 12 hours, gently rinse the ulcer with saline or water to remove remaining gel. Cover with saline-moistened gauze dressing.

Do not use any other creams, gels, or ointments at the site of the wound.

If you miss a dose of Becaplermin, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Becaplermin.

Important safety information:

Becaplermin is for external use only. Do not get Becaplermin in your eyes, nose, or mouth.

Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.

It may take several weeks for Becaplermin to work. Do not stop using Becaplermin without checking with your doctor.

Becaplermin should be used with extreme caution in CHILDREN younger than 16 years old; safety and effectiveness in these children have not been confirmed.

PREGNANCY and BREAST-FEEDING: If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Becaplermin while you are pregnant. It is not known if Becaplermin is found in breast milk. If you are or will be breast-feeding while you use Becaplermin, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Becaplermin:

All medicines may cause side effects, but many people have no, or minor side effects. When used in small doses, no COMMON side effects have been reported with Becaplermin. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); irritation.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Becaplermin side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Becaplermin may be harmful if swallowed.

Proper storage of Becaplermin:

Store Becaplermin in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Do not freeze. Do not use the gel after the expiration date at the bottom of the tube. Keep Becaplermin out of the reach of children and away from pets.

General information:

If you have any questions about Becaplermin, please talk with your doctor, pharmacist, or other health care provider.

Becaplermin is to be used only by the patient for whom it is prescribed. Do not share it with other people.

If your symptoms do not improve or if they become worse, check with your doctor.

Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Becaplermin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

More Becaplermin resources

Becaplermin Side Effects (in more detail)
Becaplermin Use in Pregnancy & Breastfeeding
Becaplermin Support Group
0 Reviews · Be the first to review/rate this drug

Thursday, 8 October 2009

Diosmin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C05CA03,C05CA53

CAS registry number (Chemical Abstracts Service)

0000520-27-4

Chemical Formula

C28-H32-O15

Molecular Weight

608

Therapeutic Categories

Capillary stabilizing agent

Antihemorrhoidal agent

Chemical Names

3',5,7-trihydroxy-4'-methoxyflavone 7-[6-O-(6-deoxy-α-L-mannopyranosyl)]-ß-D-glucopyranoside (WHO)

4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-

7-[[6-O-(Deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one (BAN)

Foreign Names

Diosminum (Latin)
Diosmin (German)
Diosmine (French)
Diosmina (Spanish)

Generic Names

Diosmin (OS: BAN)
Diosmine (OS: DCF)
Barosmin (IS)
SE 4601 (IS)
Diosmin (PH: BP 2010, Ph. Eur. 6)
Diosmine (PH: Ph. Eur. 6)
Diosminum (PH: Ph. Eur. 6)

Brand Names

Abanifan (Diosmin and Hesperidin)
Biospray, Greece

Alvenex
Alfa Wassermann, Italy

Alvenor (Diosmin and Hesperidin)
Servier, China

Anadium (Diosmin and Hesperidin)
Guardian Pharmatama, Indonesia

Ardium (Diosmin and Hesperidin)
Servier, Indonesia

Arvenum
Stroder, Italy

Arvenum (Diosmin and Hesperidin)
Servier, Luxembourg

Bioflevin (Diosmin and Hesperidin)
Alapis Pharma, Greece

Cidoston (Diosmin and Hesperidin)
Med-One, Greece

Daflavon (Diosmin and Hesperidin)
PMP, Vietnam

Daflon
Euroetika, Colombia; Euthérapie, France; Saiph, Tunisia; Servier, United Arab Emirates; Servier, Netherlands Antilles; Servier, Austria; Servier, Aruba; Servier, Barbados; Servier, Bahrain; Servier, Bermuda; Servier, Brazil; Servier, Bahamas; Servier, Switzerland; Servier, Egypt; Servier, Spain; Servier, Ghana; Servier, Guyana; Servier, Hong Kong; Servier, Iraq; Servier, Italy; Servier, Jamaica; Servier, Jordan; Servier, Kuwait; Servier, Cayman Islands; Servier, Cayman Islands; Servier, Lebanon; Servier, Saint Lucia; Servier, Myanmar; Servier, Malta; Servier, Malaysia; Servier, Nigeria; Servier, Philippines; Servier, Portugal; Servier, Qatar; Servier, Saudi Arabia; Servier, Sudan; Servier, Singapore; Servier, Syria; Servier, Thailand; Servier, Tunisia; Servier, Turkey; Servier, Trinidad & Tobago; Servier, Saint Vincent & The Grenadines; Servier, Yemen

Daflon (Diosmin and Hesperidin)
Servier, Greece; Servier, Singapore

Detralex (Diosmin and Hesperidin)
Servier, Croatia (Hrvatska); Servier, Hungary; Servier, Serbia; Servier, Slovenia

Dio
Sciencex, France

Diogam
Pharmaghreb, Tunisia

Diohes
Opsonin, Bangladesh

Dioket
Weimer, Bulgaria

Diosmil
Cooper, Luxembourg

Diosmin
Aché, Brazil

Diosmine Arrow
Arrow, France

Diosmine Biogaran
Biogaran, France

Diosmine CristerS
CristerS, France

Diosmine EG
EG Labo, France

Diosmine G Gam
Sandoz, France

Diosmine Hexal Santé
Sandoz, France

Diosmine Mylan
Mylan, France

Diosmine ratiopharm Conseil
Ratiopharm, France

Diosmine RPG
Ranbaxy, France

Diosmine Sandoz Conseil
Sandoz, France

Diosmine Teva Conseil
Teva Santé, France

Diosmine Vocate
Vocate, Greece

Diosmine Zydus
Zydus, France

Diosminex
Lek-AM, Poland

Diosper (Diosmin and Hesperidin)
Kleva, Greece; Kleva, Singapore

Diosven
CT, Italy

Dioven
Amriya, Bahrain

Diovenor
Innotech, Algeria; Innotech, France; Innothera, Tunisia; Zuoz, Venezuela

Doven
Eurofarmaco, Italy

Endium
Dexo, France

Flebon
Ivax, Argentina

Flebopex
Bago, Chile

Flebosmil
Socopharm, Luxembourg

Flébosmil
Bouchara, Luxembourg

Flebotropin
Bagó, Argentina

Flevion (Diosmin and Hesperidin)
Medicus, Greece

Flevostol (Diosmin and Hesperidin)
Bros, Greece

Hemerven
Interdelta, Switzerland

Hemorif
Square, Bangladesh

Hesmin (Diosmin and Hesperidin)
Interbat, Indonesia

Insuven
Almirall Prodesfarma, Chile

Mecaton (Diosmin and Hesperidin)
Norma, Greece

Médiveine
Elerté, France

Normanal
Renata, Bangladesh

Otrex
Stragen, Poland

Pelethrocin (Diosmin and Hesperidin)
Help Pharmaceuticals, Poland

Phlebodia
Innotech, Georgia; Innotech, Serbia; Innotech, Russian Federation; Innothera, Latvia; Innothera, Malta; Innothera, Poland

Rhodium (Diosmin and Hesperidin)
Fahrenheit, Indonesia

Sédorrhoïde Veinotonique
Cooper, France

Terbenol
Laboratorios, Argentina

Titanoral
McNeil, France

Tovene
Stada, Germany

Ven Detrex
Therabel, Belgium

Venacur
Biochem, Colombia

Venartel
Andromaco, Chile

Venex
Decomed, Portugal

Vénirène
Sanofi-Aventis, France

Veno V
Decafarma, Portugal

Venosmine
Geymonat, Italy

Venusmin
Walter Bushnell, India

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 7 October 2009

Oleandomycin

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01FA05

CAS registry number (Chemical Abstracts Service)

0003922-90-5

Chemical Formula

C35-H61-N-O12

Molecular Weight

687

Therapeutic Category

Antibacterial: Macrolide

Chemical Name

Oleandomycin

Foreign Names

Oleandomycinum (Latin)
Oleandomycin (German)
Oléandomycine (French)
Oleandomicina (Spanish)

Generic Names

Oleandomicina (OS: DCIT)
Oleandomycin (OS: BAN)
Oléandomycine (OS: DCF)
Romicil (IS)
Oleandomycin Phosphate (OS: JAN)
Oleandomycin Phosphate (PH: NF XIII)

Brand Names

OM (veterinary use)
Phibro Animal Health, United States

Mastalone Blue (Oleandomycin and Oxytetracycline, + Neomycin (veterinary use))
Pfizer Animal Health, Australia

Mastalone (Oleandomycin and Prednisolone, + Oxytetracycline, + Neomycin (veterinary use))
Pfizer Animal Health, New Zealand

Mastiguard (Oleandomycin andOxytetracycline (veterinary use))
Stockguard Animal Health, New Zealand

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thiacétarsamide sodique

Thiacétarsamide sodique may be available in the countries listed below.

Ingredient matches for Thiacétarsamide sodique

Thiacetarsamide Sodium

Thiacétarsamide sodique (DCF) is also known as Thiacetarsamide Sodium (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Humog

Humog may be available in the countries listed below.

Ingredient matches for Humog

Menotropins

Menotropins is reported as an ingredient of Humog in the following countries:

Peru

International Drug Name Search

Sunday, 4 October 2009

Pyrazinamid SAD

Pyrazinamid SAD may be available in the countries listed below.

Ingredient matches for Pyrazinamid SAD

Pyrazinamide

Pyrazinamide is reported as an ingredient of Pyrazinamid SAD in the following countries:

Denmark

International Drug Name Search

Saturday, 3 October 2009

Tropicacyl

In the US, Tropicacyl (tropicamide ophthalmic) is a member of the drug class mydriatics and is used to treat Pupillary Dilation and Refraction - Assessment.

US matches:

Tropicacyl

Ingredient matches for Tropicacyl

Tropicamide

Tropicamide is reported as an ingredient of Tropicacyl in the following countries:

Peru

United States

International Drug Name Search

Friday, 2 October 2009

Princillin

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Princillin

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Princillin in the following countries:

United States

International Drug Name Search

Monday, 26 October 2009

Ingredient matches for Nimodipino MF

Sunday, 25 October 2009

Ingredient matches for Paracetamol / Codeine Actavis

Ingredient matches for Axokine

Monday, 19 October 2009

Ingredient matches for Adcar AC

Saturday, 17 October 2009

Ingredient matches for Metizol

Tuesday, 13 October 2009

AVELOX (moxifloxacin hydrochloride - tablet; oral)

Has a generic version of Avelox been approved?

Related Patents

See also...

Becaplermin is used for:

Do NOT use Becaplermin if:

Before using Becaplermin:

How to use Becaplermin:

Important safety information:

Possible side effects of Becaplermin:

If OVERDOSE is suspected:

General information:

More Becaplermin resources

Thursday, 8 October 2009

Scheme

ATC (Anatomical Therapeutic Chemical Classification)

CAS registry number (Chemical Abstracts Service)

Chemical Formula

Molecular Weight

Therapeutic Categories

Chemical Names

Foreign Names

Generic Names

Brand Names

Wednesday, 7 October 2009

Scheme

ATC (Anatomical Therapeutic Chemical Classification)

CAS registry number (Chemical Abstracts Service)

Chemical Formula

Molecular Weight

Therapeutic Category

Chemical Name

Foreign Names

Generic Names

Brand Names

Ingredient matches for Thiacétarsamide sodique

Ingredient matches for Humog

Sunday, 4 October 2009

Ingredient matches for Pyrazinamid SAD

Saturday, 3 October 2009

Ingredient matches for Tropicacyl

Friday, 2 October 2009

Ingredient matches for Princillin